The number of prescriptions for obesity medications rose an average of 5.3% annually from 2017 to 2024 and corresponded with ...

A satirical X post saying the three major insulin manufacturers in the United States had announced 2,000%-3,000% price ...

With that as the backdrop, here's a closer look at three names that could be worth more than Berkshire Hathaway just five ...

The Danish pharma giant posted impressive data for amycretin one month after the disappointing readout of CagriSema.

Hims & Hers’ decision to advertise at the Super Bowl represents an ambitious play for the brand as it positions itself in the ...

2025 Healthcare & Pharmaceuticalscategory Outgoing FDA chief flags online weight loss drug dangers January 17, 2025 Healthcare & Pharmaceuticalscategory Novo Nordisk says its obesity drug in ...

Anti-obesity drug Mounjaro is set to rack up global sales worth nearly £22bn a year by the end of the decade. But Donald ...

Lilly boosted its online pharmacy capabilities in March via ... Telehealth firm Ro will offer low-cost, single-dose vials of Lilly's obesity drug Zepbound, the first alternative to the new ...

The former Big Brother contestant, 46, stripped completely as she flaunted her jaw-dropping figure for the X-rated Closer ...

OTTAWA – The Liberal government has spent years touting its efforts to make tech giants pay. Now, those pieces of legislation ...

In 2023, insulin manufacturer Eli Lilly voluntarily capped out-of-pocket costs for its ... to test strategies to potentially reduce prescription drug costs for people on Medicare and Medicaid. Those ...

The recent U.S. Food and Drug Administration approval for Eli Lilly and Co.'s Omvoh, a new therapy to treat Chron's disease ...